Telescope Innovations is a technology company.
Telescope Innovations has raised $3.0M across 1 funding round.
Telescope Innovations has raised $3.0M in total across 1 funding round.
Telescope Innovations Corp. is a chemical technology company specializing in developing advanced manufacturing processes and intelligent automation platforms for the pharmaceutical, chemical, and critical materials industries. Their products, such as the DirectInject-LC™ platform and the proprietary low-temperature DualPure™ method, serve pharmaceutical firms, mining companies, and engineering consultancies by accelerating chemical process development, reducing R&D and manufacturing costs, and enhancing research efficiency through robotics, AI, and advanced analytics. The company is gaining momentum through partnerships with major players like Pfizer and Standard Lithium, and government funding supports its lithium processing innovations[1][2][3][4].
Founded in Vancouver, Canada, Telescope Innovations was established by a leadership team including CEO Henry Dubina and CTO Prof. Jason Hein, backed by a scientific advisory team featuring a two-time Nobel Prize winner in Chemistry. The idea emerged from the need to modernize and automate chemical process development to meet challenges in health and sustainability. Early traction came from collaborations with pharmaceutical and mining companies and the successful deployment of their automation platforms and proprietary manufacturing processes, such as the lithium sulfide production technology DualPure™[2][3][4].
Telescope Innovations rides the growing trend of automation and AI integration in chemical manufacturing and pharmaceutical R&D, addressing the increasing demand for faster, cost-effective, and sustainable production methods. The timing is critical as industries seek to innovate in battery materials and drug development amid global sustainability and supply chain challenges. Their work in lithium recycling and solid-state battery materials positions them at the forefront of clean energy technology, influencing both the biotech and advanced manufacturing ecosystems[1][3][4].
Looking ahead, Telescope Innovations is poised to expand its impact by scaling up lithium processing technologies and further automating chemical manufacturing. Trends such as AI-driven automation, sustainability in materials science, and the push for advanced battery technologies will shape their trajectory. Their influence is likely to grow as they continue to secure government funding, deepen industry partnerships, and commercialize proprietary processes, reinforcing their role as a key innovator at the intersection of chemistry, automation, and sustainability[3][4][5].
Telescope Innovations has raised $3.0M in total across 1 funding round.
Telescope Innovations's investors include Endeavor Venture Funds, New Age Ventures, Next Coast Ventures, Redpoint Ventures, S3 Ventures, Tensility Venture Partners, True Wealth Ventures.
Telescope Innovations has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Series A in April 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2021 | $3.0M Series A | Endeavor Venture Funds, New Age Ventures, Next Coast Ventures, Redpoint Ventures, S3 Ventures, Tensility Venture Partners, True Wealth Ventures |